July 25, 2025

Blenrep now approved in Canada and EU for relapsed/refractory multiple myeloma after one prior treatment.

July 25, 2025

Learn how to avoid misleading Medicare sales tactics and stay informed during open enrollment and Medicaid changes.

July 07, 2025

Key insights from Mount Sinai’s HealthTree tour: myeloma risks, CAR-T advances, trials, and quality-of-life research.

July 01, 2025

In vivo CAR T-cell therapy may make blood cancer treatment safer, faster, and more accessible.

June 23, 2025

Myeloma death rates are higher for lower-income and rural patients. Learn how income and location impact care access.